Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-65 |
filingDate |
2000-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16592c05fa5cde5fc5324e5dcaffb23b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde12e94cf14ee8a653cc94d0d6b7aad |
publicationDate |
2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2702760-C |
titleOfInvention |
Insulin-like growth factor (igf) i mutant variants |
abstract |
IGF-I and insulin variants are provided that selectively bind to IGFBP-1 or IGFBP-3. These agonist variants are useful, for example, to improve the half-lives of IGF-I and insulin, respectively. |
priorityDate |
1999-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |